The New York attorney general’s office has filed suit against the former CEO of Emergent Biosolutions Inc., alleging insider trading, while at the same time announcing a settlement with the company, ...
More than 3,000 prescriptions were written for Novo’s GLP-1 pill in its first week on the market. Elsewhere, Emergent reached ...
Daily Voice on MSN
NY AG sues former Emergent CEO over insider trading
A former biotech CEO pocketed more than $10 million by selling company stock after learning of serious COVID-19 vaccine ...
Emergent BioSolutions Inc. (NYSE:EBS) is one of the Best Performing Affordable Stocks Under $40. On January 8, Emergent ...
The FDA removed some webpages saying cellphones aren't dangerous amid HHS plans to study cellphone radiation. Secretary ...
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article ...
Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with ...
New York's attorney general has filed an insider trading lawsuit against former Emergent BioSolutions CEO Robert Kramer, ...
New York Attorney General sued the former CEO of Emergent BioSolutions, Robert G. Kramer, for insider trading.
New York AG Letitia James charged former Emergent BioSolutions CEO Robert Kramer with insider trading tied to COVID-19 ...
New York AG Tish James sued former Emergent BioSolutions CEO over alleged insider trading around the COVID vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback